Pulmonary sarcoidosis

The Lancet Respiratory Medicine

Volumn 6, Issue 5, 2018, Pages 389-402

  Spagnolo, Paolo ^a   Rossi, Giulio ^b   Trisolini, Rocco ^c   Sverzellati, Nicola ^d   Baughman, Robert P ^e   Wells, Athol U ^f  

^a UNIVERSITY OF PADOVA   (Italy)

^b SANTA MARIA DELLE CROCI HOSPITAL   (Italy)

^c UNIVERSITY OF BOLOGNA   (Italy)

^d UNIVERSITY OF PARMA   (Italy)

^e UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

^f ROYAL BROMPTON AND HAREFIELD NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIOPSY; BRONCHOSCOPY; COMPLICATION; DIAGNOSTIC IMAGING; DISEASE EXACERBATION; ECHOGRAPHY; FATIGUE; FEMALE; HUMAN; LUNG; LUNG ASPERGILLOSIS; LUNG SARCOIDOSIS; MALE; PATHOLOGY; PULMONARY HYPERTENSION; SEVERITY OF ILLNESS INDEX; SEX RATIO; X-RAY COMPUTED TOMOGRAPHY;

BIOPSY; BRONCHOSCOPY; DISEASE PROGRESSION; FATIGUE; FEMALE; HUMANS; HYPERTENSION, PULMONARY; LUNG; MALE; PULMONARY ASPERGILLOSIS; SARCOIDOSIS, PULMONARY; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION; TOMOGRAPHY, X-RAY COMPUTED; ULTRASONOGRAPHY;

EID: 85044730224     PISSN: 22132600     EISSN: 22132619     Source Type: Journal    
DOI: 10.1016/S2213-2600(18)30064-X     Document Type: Review

References (109)

1. Hutchinson J. Anomalous diseases of skin ad fingers; case of livid papillary psoriasis? In: Churchill J, Churchill A, eds. Illustrations of Clinical Surgery. London. 1877: 42–43.
2. Rybicki, BA, Maliarik, MJ, Major, M, Popovich, J Jr, Iannuzzi, MC, Epidemiology, demographics, and genetics of sarcoidosis. Semin Respir Infect 13 (1998), 166–173.
3. Cozier, YC, Assessing the worldwide epidemiology of sarcoidosis: challenges and future directions. Eur Respir J 48 (2016), 1545–1548.
4. Grunewald, J, Spagnolo, P, Wahlström, J, Eklund, A, Immunogenetics of disease-causing inflammation in sarcoidosis. Clin Rev Allergy Immunol 49 (2015), 19–35.
5. Gerke, AK, Judson, MA, Cozier, YC, Culver, DA, Koth, LL, Disease burden and variability in sarcoidosis. Ann Am Thorac Soc, 14, 2017, S421.
6. Kirkil, G, Lower, EE, Baughman, RP, Predictors of mortality in pulmonary sarcoidosis. Chest 153 (2017), 105–113.
7. Walsh, SL, Wells, AU, Sverzellati, N, et al. An integrated clinicoradiological staging system for pulmonary sarcoidosis: a case-cohort study. Lancet Respir Med 2 (2014), 123–130.
8. Khan, NA, Donatelli, CV, Tonelli, AR, et al. Toxicity risk from glucocorticoids in sarcoidosis patients. Respir Med 132 (2017), 9–14.
9. Spagnolo, P, Sarcoidosis: a critical review of history and milestones. Clinic Rev Allerg Immunol 49 (2015), 1–5.
10. Arkema, EV, Grunewald, J, Kullberg, S, Eklund, A, Askling, J, Sarcoidosis incidence and prevalence: a nationwide register-based assessment in Sweden. Eur Respir J 48 (2016), 1690–1699.
11. Rybicki, BA, Major, M, Popovich, J Jr, Maliarik, MJ, Iannuzzi, MC, Racial differences in sarcoidosis incidence: a 5-year study in a health maintenance organization. Am J Epidemiol 145 (1997), 234–241.
12. Baughman, RP, Field, S, Costabel, U, et al. Sarcoidosis in America. Analysis based on health care use. Ann Am Thorac Soc 13 (2016), 1244–1252.
13. Gribbin, J, Hubbard, RB, Le Jeune, I, et al. Incidence and mortality of idiopathic pulmonary fibrosis and sarcoidosis in the UK. Thorax 61 (2006), 980–985.
14. Duchemann, B, Annesi-Maesano, I, Jacobe de Naurois, C, et al. Prevalence and incidence of interstitial lung diseases in a multi-ethnic county of Greater Paris. Eur Respir J, 50, 2017, 1602419.
15. Morimoto, T, Azuma, A, Abe, S, et al. Epidemiology of sarcoidosis in Japan. Eur Respir J 31 (2008), 372–379.
16. Fisher, A, Grunewald, J, Spagnolo, P, Nebel, A, Schreiber, S, Müller-Quernheim, J, Genetics of sarcoidosis. Semin Respir Care Med 35 (2014), 296–306.
17. Chen, ES, Moller, DR, Etiologies of sarcoidosis. Clin Rev Allergy Immunol 49 (2015), 6–18.
18. Le Jeune, I, Gribbin, J, West, J, et al. The incidence of cancer in patients with idiopathic pulmonary fibrosis and sarcoidosis in the UK. Respir Med 101 (2007), 2534–2540.
19. Askling, J, Grunewald, J, Eklund, A, et al. Increased risk for cancer following sarcoidosis. Am J Respir Crit Care Med 160 (1999), 1668–1672.
20. Søgaard, KK, Sværke, C, Thomsen, RW, Nørgaard, M, Sarcoidosis and subsequent cancer risk: a Danish nationwide cohort study. Eur Respir J 45 (2015), 269–272.
21. Mirsaeidi, M, Machado, RF, Schraufnagel, D, Sweiss, NJ, Baughman, RP, Racial difference in sarcoidosis mortality in the United States. Chest 147 (2015), 438–449.
22. Swigris, JJ, Olson, AL, Huie, TJ, et al. Sarcoidosis-related mortality in the United States from 1988–2007. Am J Respir Crit Care Med 183 (2011), 1524–1530.
23. Nardi, A, Brillet, PY, Letoumelin, P, et al. Stage IV sarcoidosis: comparison of survival with the general population and causes of death. Eur Respir J 38 (2011), 1368–1373.
24. Sekiguchi, M, Numao, Y, Imai, M, Furuie, T, Mikami, R, Clinical and histopathological profile of sarcoidosis of the heart and acute idiopathic myocarditis. Concepts through a study employing endomyocardial biopsy. I. Sarcoidosis. Jpn Circ J 44 (1980), 249–263.
25. Jamilloux, Y, Maucort-Boulch, D, Kerever, S, et al. Sarcoidosis-related mortality in France: a multiple-cause-of-death analysis. Eur Respir J 48 (2016), 1700–1709.
26. Ungprasert, P, Carmona, EM, Utz, JP, Ryu, JH, Crowson, CS, Matteson, EL, Epidemiology of sarcoidosis 1946–2013: a population-based study. Mayo Clin Proc 91 (2016), 183–188.
27. Valeyre, D, Prasse, A, Nunes, H, Uzunhan, Y, Brillet, PY, Müller-Quernheim, J, Sarcoidosis. Lancet 383 (2014), 1155–1167.
28. Culver, DA, Diagnosing sarcoidosis. Curr Opin Pulm Med 21 (2015), 499–509.
29. Hunninghake, GW, Costabel, U, Ando, M, et al. ATS/ERS/WASOG statement on sarcoidosis. American Thoracic Society/European Respiratory Society/World Association of Sarcoidosis and other granulomatous disorders. Sarcoidosis Vasc Diffuse Lung Dis 16 (1999), 149–173.
30. Teirstein, AS, Judson, MA, Baughman, RP, Rossman, MD, Yeager, H Jr, Moller, DR, Case control etiologic study of sarcoidosis (ACCESS) writing group. The spectrum of biopsy sites for the diagnosis of sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 22 (2005), 139–146.
31. Trisolini, R, Tinelli, C, Cancellieri, A, et al. Transbronchial needle aspiration in sarcoidosis: yield and predictors of a positive aspirate. J Thorac Cardiovasc Surg 135 (2008), 837–842.
32. Wong, M, Yasufuku, K, Nakajima, T, et al. Endobronchial ultrasound: new insight for the diagnosis of sarcoidosis. Eur Respir J 29 (2007), 1182–1186.
33. Garwood, S, Judson, MA, Silvestri, G, Hoda, R, Fraig, M, Doelken, P, Endobronchial ultrasound for the diagnosis of pulmonary sarcoidosis. Chest 132 (2007), 1298–1304.
34. Nakajima, T, Yasufuku, K, Kurosu, K, et al. The role of EBUS-TBNA for the diagnosis of sarcoidosis: comparisons with other bronchoscopic diagnostic modalities. Respir Med 103 (2009), 1796–1800.
35. Plit, ML, Havryk, AP, Hodgson, A, et al. Rapid cytological analysis of endobronchial ultrasound-guided aspirates in sarcoidosis. Eur Respir J 42 (2013), 1302–1308.
36. Shorr, AF, Torrington, KG, Hnatiuk, OW, Endobronchial biopsy for sarcoidosis: a prospective study. Chest 120 (2001), 109–114.
37. Von Bartheld, MB, Dekkers, OM, Szlubovski, M, et al. Endosonography vs conventional bronchoscopy for the diagnosis of sarcoidosis: the GRANULOMA randomized clinical trial. JAMA 309 (2013), 2457–2464.
38. Agarwal, R, Srinivasan, A, Aggarwal, AN, Gupta, D, Efficacy and safety of convex probe EBUS-TBNA in sarcoidosis: a systematic review and meta-analysis. Respir Med 106 (2012), 883–892.
39. Trisolini, R, Lazzari Agli, L, Tinelli, C, De Silvestri, A, Scotti, V, Patelli, M, Endobronchial ultrasound-guided transbronchial needle aspiration for diagnosis of sarcoidosis in clinically unselected study populations. Respirology 20 (2015), 226–234.
40. Dhooria, S, Agarwal, R, Aggarwal, AN, Bal, A, Gupta, N, Gupta, D, Differentiating tuberculosis from sarcoidosis by sonographic characteristics of lymph nodes on endobronchial ultrasonography: a study of 165 patients. J Thorac Cardiovasc Surg 148 (2014), 662–667.
41. Navani, N, Molyneaux, PL, Breen, LA, et al. Utility of endobronchial ultrasound-guided transbronchial needle aspiration in patients with tuberculous intrathoracic lymphadenopathy: a multicentre study. Thorax 66 (2011), 889–893.
42. Steinfort, DP, Tsui, A, Grieve, J, et al. Sarcoidal reactions in regional lymph nodes of patients with early stage non-small cell lung cancer predict improved disease-free survival: a pilot case–control study. Hum Pathol 43 (2012), 333–338.
43. Pajares, V, Puzo, C, Castillo, D, et al. Diagnostic yield of transbronchial cryobiopsy in interstitial lung disease: a randomized trial. Respirology 19 (2014), 900–906.
44. Aragaki-Nagahodo, AA, Baughman, RP, Shipley, RT, Benzaquen, S, The complimentary role of transbronchial lung cryobiopsy and endobronchial ultrasound fine needle aspiration in the diagnosis of sarcoidosis. Respir Med 131 (2017), 65–69.
45. Rossi, G, Cavazza, A, Colby, TV, Pathology of sarcoidosis. Clin Rev Allergy Immunol 49 (2015), 36–44.
46. Takemura, T, Matsui, Y, Saiki, S, Mikami, R, Pulmonary vascular involvement in sarcoidosis: a report of 40 autopsy cases. Hum Pathol 23 (1992), 1216–1223.
47. Costabel, U, Zeiss, AW, Guzman, J, Sensitivity and specificity of BAL findings in sarcoidosis. Sarcoidosis 9 (1992), 211–214.
48. Winterbauer, RH, Lammert, J, Selland, M, et al. Bronchoalveolar lavage cell populations in the diagnosis of sarcoidosis. Chest 104 (1993), 352–361.
49. Nagai, S, Izumi, T, Bronchoalveolar lavage. Still useful in diagnosing sarcoidosis?. Clin Chest Med 18 (1997), 787–797.
50. Danila, E, Jurgauskiene, L, Malickaite, R, BAL fluid cells and pulmonary function in different radiographic stages of newly diagnosed sarcoidosis. Adv Med Sci 53 (2008), 228–233.
51. Colby, TV, The pathologist's approach to bronchoscopic biopsies. Pathologica 102 (2010), 432–442.
52. Takayama, K, Nagata, N, Miyagawa, Y, Hirano, H, Shigematsu, N, The usefulness of step sectioning of transbronchial lung biopsy specimen in diagnosing sarcoidosis. Chest 102 (1992), 1441–1443.
53. Casoni, GL, Tomassetti, S, Cavazza, A, et al. Transbronchial lung cryobiopsy in the diagnosis of fibrotic interstitial lung diseases. PLoS One, 9, 2014, e86716.
54. Hutton Klein, JR, Tazelaar, HD, Leslie, KO, Colby, TV, One hundred consecutive granulomas in a pulmonary pathology consultation practice. Am J Surg Pathol 34 (2010), 1456–1464.
55. Hsu, RM, Connors, AF Jr, Tomashefski, JF Jr, Histologic, microbiologic and clinical correlates of the diagnosis of sarcoidosis by transbronchial biopsy. Arch Pathol Lab Med 120 (1996), 364–368.
56. Scadding, JG, Prognosis of intrathoracic sarcoidosis in England. A review of 136 cases after five years' observation. Br Med J 2 (1961), 1165–1172.
57. Spagnolo, P, Sverzellati, N, Wells, AU, Hansell, DM, Imaging aspects of the diagnosis of sarcoidosis. Eur Radiol 24 (2014), 807–816.
58. Miller, BH, Putman, CE, The chest radiograph and sarcoidosis. Reevaluation of the chest radiograph in assessing activity of sarcoidosis: a preliminary communication. Sarcoidosis 2 (1985), 85–90.
59. Baughman, RP, Teirstein, AS, Judson, MA, et al. Clinical characteristics of patients in a case control study of sarcoidosis. Am J Respir Crit Care Med 164 (2001), 1885–1889.
60. Loddenkemper, R, Kloppenborg, A, Schoenfeld, N, Grosser, H, Costabel, U, Clinical findings in 715 patients with newly detected pulmonary sarcoidosis—results of a cooperative study in former West Germany and Switzerland. WATL Study Group. Wissenschaftliche Arbeitsgemeinschaft fur die Therapie von Lungenkrankheitan. Sarcoidosis Vasc Diffuse Lung Dis 15 (1998), 178–182.
61. Calandriello, L, Walsh, SLF, Imaging for sarcoidosis. Semin Respir Crit Care Med 38 (2017), 417–436.
62. Brauner, MW, Grenier, P, Mompoint, D, Lenoir, S, de Crémoux, H, Pulmonary sarcoidosis: evaluation with high-resolution CT. Radiology 172 (1989), 467–471.
63. Abehsera, M, Valeyre, D, Grenier, P, Jaillet, H, Battesti, JP, Brauner, MW, Sarcoidosis with pulmonary fibrosis: CT patterns and correlation with pulmonary function. AJR Am J Roentgenol 174 (2000), 1751–1757.
64. Udwadia, ZF, Pilling, JR, Jenkins, PF, Harrison, BD, Bronchoscopic and bronchographic findings in 12 patients with sarcoidosis and severe or progressive airways obstruction. Thorax 45 (1990), 272–275.
65. Nunes, H, Humbert, M, Capron, F, et al. Pulmonary hypertension associated with sarcoidosis: mechanisms, haemodynamics and prognosis. Thorax 61 (2006), 68–74.
66. Judson, MA, Thompson, BW, Rabin, DL, et al. The diagnostic pathway to sarcoidosis. Chest 123 (2003), 406–412.
67. Harrison, BD, Shaylor, JM, Stokes, TC, Wilkes, AR, Airflow limitation in sarcoidosis: a study of pulmonary function in 107 patients with newly diagnosed disease. Respir Med 85 (1991), 59–64.
68. Gafà, G, Sverzellati, N, Bonati, E, et al. Follow-up in pulmonary sarcoidosis: comparison between HRCT and pulmonary function tests. Radiol Med 117 (2012), 968–978.
69. Zappala, CJ, Desai, SR, Copley, SJ, et al. Accuracy of individual variables in the monitoring of long-term change in pulmonary sarcoidosis as judged by serial high-resolution CT scan data. Chest 145 (2014), 101–107.
70. Cordova, FC, D'Alonzo, G, Sarcoidosis-associated pulmonary hypertension. Curr Opin Pulm Med 19 (2013), 531–537.
71. Baughman, RP, Engel, PJ, Taylor, L, et al. Survival in sarcoidosis associated pulmonary hypertension: the importance of hemodynamic evaluation. Chest 138 (2010), 1078–1085.
72. Handa, T, Nagai, S, Miki, S, et al. Incidence of pulmonary hypertension and its clinical relevance in patients with sarcoidosis. Chest 129 (2006), 1246–1252.
73. Janda, S, Shahidi, N, Gin, K, Swiston, J, Diagnostic accuracy of echocardio-graphy for pulmonary hypertension: a systematic review and meta-analysis. Heart 97 (2011), 612–622.
74. Baughman, RP, Culver, DA, Cordova, FC, et al. Bosentan for sarcoidosis-associated pulmonary hypertension: a double-blind placebo controlled randomized trial. Chest 145 (2014), 810–817.
75. Denning, DW, Pleuvry, A, Cole, DC, Global burden of chronic pulmonary aspergillosis complicating sarcoidosis. Eur Respir J 41 (2013), 621–626.
76. Uzunhan, Y, Nunes, H, Jeny, F, et al. Chronic pulmonary aspergillosis complicating sarcoidosis. Eur Respir J, 49, 2017, 1602396.
77. Keir, GJ, Garfield, B, Hansell, DM, et al. Cyclical caspofungin for chronic pulmonary aspergillosis in sarcoidosis. Thorax 69 (2014), 287–288.
78. Pena, T, Soubani, AO, Samavati, L, Aspergillus lung disease in patients with sarcoidosis: a case series and review of the literature. Lung 189 (2011), 167–172.
79. Kravitz, JN, Berry, MW, Schabel, SI, et al. A modern series of percutaneous intracavitary instillation of amphotericin B for the treatment of severe hemoptysis from pulmonary aspergilloma. Chest 143 (2013), 1414–1421.
80. Panselinas, E, Judson, MA, Acute pulmonary exacerbations of sarcoidosis. Chest 142 (2012), 827–836.
81. Baughman, RP, Lower, EE, Frequency of acute worsening events in fibrotic pulmonary sarcoidosis patients. Respir Med 107 (2013), 2009–2013.
82. Drent, M, Lower, EE, De Vries, J, Sarcoidosis-associated fatigue. Eur Respir J 40 (2012), 255–263.
83. Eklund, A, du Bois, RM, Approaches to the treatment of some of the troublesome manifestations of sarcoidosis. J Intern Med 275 (2014), 335–349.
84. Korenromp, IH, Heijnen, CJ, Vogels, OJ, van den Bosch, JM, Grutters, JC, Characterization of chronic fatigue in sarcoidosis in clinical remission. Chest 140 (2011), 441–447.
85. Patel, AS, Siegert, RJ, Creamer, D, et al. The development and validation of the King's Sarcoidosis Questionnaire for the assessment of health status. Thorax 68 (2013), 57–65.
86. De Vries, J, Michielsen, H, Van Heck, GL, Drent, M, Measuring fatigue in sarcoidosis: the Fatigue Assessment Scale (FAS). Br J Health Psychol 9 (2004), 279–291.
87. Paramothayan, NS, Lasserson, TJ, Jones, PW, Corticosteroids for pulmonary sarcoidosis. Cochrane Database Syst Rev, 2, 2005 CD001114.
88. Baughman, RP, Grutters, JC, New treatment strategies for pulmonary sarcoidosis: antimetabolites, biological drugs, and other treatment approaches. Lancet Respir Med 3 (2015), 813–822.
89. Neville, E, Walker, AN, James, DG, Prognostic factors predicting the outcome of sarcoidosis: an analysis of 818 patients. Q J Med 52 (1983), 525–533.
90. Mañá, J, Gómez-Vaquero, C, Montero, A, et al. Löfgren's syndrome revisited: a study of 186 patients. Am J Med 107 (1999), 240–255.
91. Lower, EE, Malhotra, A, Surdulescu, V, Baughman, RP, Armodafinil for sarcoidosis-associated fatigue: a double-blind, placebo-controlled, crossover trial. J Pain Symptom Manage 45 (2013), 159–169.
92. Vorselaars, AD, Wuyts, WA, Vorselaars, VM, et al. Methotrexate vs azathioprine in second-line therapy of sarcoidosis. Chest 144 (2013), 805–812.
93. Hamzeh, N, Voelker, A, Forssén, A, et al. Efficacy of mycophenolate mofetil in sarcoidosis. Respir Med 108 (2014), 1663–1669.
94. Baughman, RP, Drent, M, Kavuru, M, et al. Infliximab therapy in patients with chronic sarcoidosis and pulmonary involvement. Am J Respir Crit Care Med 174 (2006), 795–802.
95. Rossman, MD, Newman, LS, Baughman, RP, et al. A double-blinded, randomized, placebo-controlled trial of infliximab in subjects with active pulmonary sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 23 (2006), 201–208.
96. Vorselaars, AD, Crommelin, HA, Deneer, VH, et al. Effectiveness of infliximab in refractory FDG PET-positive sarcoidosis. Eur Respir J 46 (2015), 175–185.
97. Ziegenhagen, MW, Benner, UK, Zissel, G, et al. Sarcoidosis: TNF-α release from alveolar macrophages and serum level of sIL-2R are prognostic markers. Am J Respir Crit Care Med 156 (1997), 1586–1592.
98. Ziegenhagen, MW, Rothe, ME, Schlaak, M, Müller-Quernheim, J, Bronchoalveolar and serological parameters reflecting the severity of sarcoidosis. Eur Respir J 21 (2003), 407–413.
99. Keicho, N, Kitamura, K, Takaku, F, et al. Serum concentration of soluble interleukin-2 receptor as a sensitive parameter of disease activity in sarcoidosis. Chest 98 (1990), 1125–1129.
100. Grutters, JC, Fellrath, JM, Mulder, L, et al. Serum soluble interleukin-2 receptor measurement in patients with sarcoidosis: a clinical evaluation. Chest 124 (2003), 186–195.
101. Lukacs, NW, Chensue, SW, Strieter, RM, Warmington, K, Kunkel, SL, Inflammatory granuloma formation is mediated by TNF-α-inducible intercellular adhesion molecule-1. J Immunol 152 (1994), 5883–5889.
102. Ziegenhagen, MW, Rothe, ME, Zissel, G, Müller-Quernheim, J, Exaggerated TNFα release of alveolar macrophages in corticosteroid resistant sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 19 (2002), 185–190.
103. Wijnen, PA, Cremers, JP, Nelemans, PJ, et al. Association of the TNF-α G-308A polymorphism with TNF-inhibitor response in sarcoidosis. Eur Respir J 43 (2014), 1730–1739.
104. Taimeh, Z, Hertz, MI, Shumway, S, Pritzker, M, Lung transplantation for pulmonary sarcoidosis. Twenty-five years of experience in the USA. Thorax 71 (2016), 378–379.
105. Yusen, RD, Christie, JD, Edwards, LB, et al. The Registry of the International Society for Heart and Lung Transplantation: thirtieth adult lung and heart-lung transplant report—2013; focus theme: age. J Heart Lung Transplant 32 (2013), 965–978.
106. Shorr, AF, Helman, DL, Davies, DB, et al. Sarcoidosis, race and short-term outcomes following lung transplantation. Chest 125 (2004), 990–996.
107. Hadjiliadis, D, Sporn, TA, Perfect, JR, et al. Outcome of lung transplantation in patients with mycetomas. Chest 121 (2002), 128–134.
108. Shlobin, OA, Nathan, SD, Management of end-stage sarcoidosis: pulmonary hypertension and lung transplantation. Eur Respir J 39 (2012), 1520–1533.
109. Valeyre, D, Nunes, H, Bernaudin, J-F, Advanced pulmonary sarcoidosis. Curr Opin Pulm Med 20 (2014), 488–495.